Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Pacific Biosciences of California    P09

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
09/18/2017 09/19/2017 09/20/2017 09/21/2017 09/22/2017 Date
4.451(c) 4.432(c) 4.393(c) 4.338(c) 4.206(c) Last
0 0 0 0 0 Volume
+2.11% -0.43% -0.88% -1.25% -3.04% Change
More quotes
Financials ($)
Sales 2017 106 M
EBIT 2017 -87,9 M
Net income 2017 -91,0 M
Debt 2017 0,60 M
Yield 2017 -
Sales 2018 132 M
EBIT 2018 -71,8 M
Net income 2018 -74,7 M
Finance 2018 0,27 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 5,61x
EV / Sales2018 4,48x
Capitalization 592 M
More Financials
Company
Pacific Biosciences of California, Inc. engages in the research, development and manufacture of sequencing systems for genetic analysis.It operates through the following geographical segments: North America, Europe, and Asia.It offers deoxyribonucleic acid sequencing, third generation sequencing... 
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Latest news on PACIFIC BIOSCIENCES OF CAL
08/24 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Molecular Redundant Sequen..
08/18 PACIFIC BIOSCIENCES OF CALIFORNIA : Presolicitation Notice - Instruments & Labor..
08/03 PACIFIC BIOSCIENCES OF CALIFORNIA : PacBio Announces New Agreement with Novogene..
08/03 PACIFIC BIOSCIENCES OF CALIFORNIA : reports 2Q loss
08/02 PACIFIC BIOSCIENCES OF CALIFORNIA : Management's Discussion and Analysis of Fina..
08/02 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Results of Operations and Financial Condi..
08/02 PacBio Announces New Agreement with Novogene to Purchase Ten Sequel Systems
08/02 Pacific Biosciences of California, Inc. Announces Second Quarter 2017 Financi..
08/02 PACIFIC BIOSCIENCES OF CALIFORNIA : Investor Network: Pacific Biosciences of Cal..
07/25 Pacific Biosciences of California, Inc. Second Quarter 2017 Financial Results..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
08/31DJROYAL PHILIPS : Prices Offering of Notes for EUR1.0 Billion
08/03DJHot Stocks to Watch in the U.S. and Canada
07/24 Autos, airlines hit in sluggish start to European trading week
07/24 ROYAL PHILIPS : Philips targets order book growth of 4-6 percent in 2017 - CEO
07/24DJROYAL PHILIPS : 2Q Net Profit Rises; Begins EUR1.5 Billion Share Buyback Program
More sector news : Advanced Medical Equipment & Technology - NEC
Chart PACIFIC BIOSCIENCES OF CAL
Duration : Period :
Pacific Biosciences of Cal Technical Analysis Chart | P09 | US69404D1081 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 5,95 $
Spread / Average Target 16%
EPS Revisions
Managers
NameTitle
Michael W. Hunkapiller Executive Chairman, President & CEO
Susan K. Barnes CFO, Principal Accounting Officer & Executive VP
Stephen W. Turner Chief Technical Officer & Vice President
James Michael Phillips Senior Vice President-Research & Development
Jonas Korlach Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF CALIFORNIA18.65%592
THERMO FISHER SCIENTIFIC INC.33.18%75 111
DANAHER11.02%60 285
BOSTON SCIENTIFIC CORPORATION33.33%39 586
ROYAL PHILIPS21.62%39 413
INTUITIVE SURGICAL62.45%38 322